By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Boehringer Ingelheim Corporation 

P.O. Box 368
900 Ridgebury Road
Ridgefield  Connecticut  06877-0368  U.S.A.
Phone: 203-798-99-88 Fax: 203-791-62-34


SEARCH JOBS








Company News
Boehringer Ingelheim Release: IPF Patients Treated With Ofev (Nintedanib) Versus Placebo Were Twice As Likely To Have Improved Or Stable Lung Function 5/24/2017 7:45:49 AM
Boehringer Ingelheim Release: IPF Patients Treated With OFEV (Nintedanib) Versus Placebo Were Twice As Likely To Have Improved Or Stable Lung Function 5/24/2017 7:20:57 AM
Boehringer Ingelheim Release: American Thoracic Society 2017 Spiriva Respimat Improves Breathing For People With Asthma Regardless Of BMI Or Allergic Status 5/23/2017 9:51:11 AM
Boehringer Ingelheim Strengthens Early Science Portfolio Through Comprehensive Multifaceted Partnership With Peking University 5/16/2017 8:16:41 AM
Boehringer Ingelheim Inaugurates World-Class Biopharmaceutical Manufacturing Facility in China 5/16/2017 7:20:04 AM
Zealand Pharma  (ZEAL.CO) Discloses Amylin As The Biological Target Under Their 2014 Agreement With Boehringer Ingelheim 5/11/2017 11:33:08 AM
Boehringer Ingelheim Phase III Study Now Enrolling Patients with Progressive Fibrosing Lung Diseases 4/19/2017 6:26:23 AM
Boehringer Ingelheim: A New World Leader In Animal Health 4/5/2017 7:57:03 AM
Novozymes (NVZMY) And Boehringer Ingelheim Announce Strategic Collaboration In Probiotics For Poultry Hatcheries 3/30/2017 7:07:49 AM
Boehringer Ingelheim Release: Uninterrupted Pradaxa (Dabigatran Etexilate Mesylate) Showed Less Major Bleeding Than Warfarin In Atrial Fibrillation Patients Undergoing Catheter Ablation 3/20/2017 7:53:25 AM
12345678910...
//-->